Try our corporate solution for free!
(212) 419-8286

Gilead Sciences' top products based on revenue 2018-2020

This statistic shows the top products of biopharmaceutical company Gilead Sciences from 2018 to 2020, based on revenue. Gilead Sciences Inc. is headquartered in California and is specialized in discovering, developing and commercializing therapeutics. In 2020, Gilead Sciences' COVID-19 treatment Veklury (remdesivir) generated some 2.8 billion U.S. dollars in revenue.

Leading products of Gilead Sciences from 2018 to 2020 based on revenue

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until May 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2021



Survey time period

2018 to 2020

Special properties

Supplementary notes

* Amounts consist of sales of Epclusa and the authorized generic version of Epclusa sold by our separate subsidiary, Asegua Therapeutics LLC.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus: the pharma and medtech response"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.